These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
875 related items for PubMed ID: 7476882
1. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells. Leduc I, Haddad P, Giasson E, Meloche S. Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882 [Abstract] [Full Text] [Related]
5. Signal transduction by basic fibroblast growth factor in rat osteoblastic Py1a cells. Hurley MM, Marcello K, Abreu C, Kessler M. J Bone Miner Res; 1996 Sep; 11(9):1256-63. PubMed ID: 8864900 [Abstract] [Full Text] [Related]
7. Human IL-3 receptor signaling: rapid induction of phosphatidylcholine hydrolysis is independent of protein kinase C but dependent on tyrosine phosphorylation in transfected NIH 3T3 cells. Rao P, Kitamura T, Miyajima A, Mufson RA. J Immunol; 1995 Feb 15; 154(4):1664-74. PubMed ID: 7836750 [Abstract] [Full Text] [Related]
9. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Anel A, Buferne M, Boyer C, Schmitt-Verhulst AM, Golstein P. Eur J Immunol; 1994 Oct 15; 24(10):2469-76. PubMed ID: 7523141 [Abstract] [Full Text] [Related]
12. The role of tyrosine phosphorylation in signal transduction through surface Ig in human B cells. Inhibition of tyrosine phosphorylation prevents intracellular calcium release. Lane PJ, Ledbetter JA, McConnell FM, Draves K, Deans J, Schieven GL, Clark EA. J Immunol; 1991 Jan 15; 146(2):715-22. PubMed ID: 1702814 [Abstract] [Full Text] [Related]
14. Redox regulation of signal transduction in smooth muscle cells: distinct effects of PKC-down regulation and PKC inhibitors on oxidant induced MAP kinase. Taher MM, Mahgoub MA, Abd-Elfattah AS. J Recept Signal Transduct Res; 1998 Jan 15; 18(2-3):167-85. PubMed ID: 9651884 [Abstract] [Full Text] [Related]
15. Effects of genistein and staurosporine on angiotensin II-induced DNA synthesis, protein synthesis and mitogen-activated protein kinase activation in vascular smooth muscle cells. Hanada M, Saito E, Kambe T, Hagiwara Y, Kubo T. Biol Pharm Bull; 1998 Oct 15; 21(10):1045-9. PubMed ID: 9821807 [Abstract] [Full Text] [Related]
16. Tyrosine kinase inhibition affects type 1 angiotensin II receptor internalization. Becker BN, Kondo S, Chen JK, Harris RC. J Recept Signal Transduct Res; 1999 Nov 15; 19(6):975-93. PubMed ID: 10533984 [Abstract] [Full Text] [Related]
17. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells. Shimokado K, Umezawa K, Ogata J. Exp Cell Res; 1995 Oct 15; 220(2):266-73. PubMed ID: 7556433 [Abstract] [Full Text] [Related]
18. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells. Koh E, Morimoto S, Tomita J, Rakugi H, Jiang B, Inoue T, Nabata T, Fukuo K, Ogihara T. J Cardiovasc Pharmacol; 1994 Feb 15; 23(2):175-9. PubMed ID: 7511744 [Abstract] [Full Text] [Related]
19. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction. Watts SW, Florian JA, Monroe KM. J Pharmacol Exp Ther; 1998 Sep 15; 286(3):1431-8. PubMed ID: 9732408 [Abstract] [Full Text] [Related]